醛糖还原酶抑制剂与糖尿病并发症 - Suppr

Suppr

超能文献

Aldose reductase inhibitors and the complications of diabetes mellitus.

作者信息

Tomlinson D R

机构信息

Department of Pharmacology, Queen Mary and Westfield College, London, UK.

出版信息

Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.

DOI:10.1111/j.1464-5491.1993.tb00049.x

PMID:8485953

Abstract

摘要

相似文献

Aldose reductase inhibitors and the complications of diabetes mellitus.

Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.

Aldose reductase inhibitors and diabetic complications.

Am J Med. 1987 Aug;83(2):298-306. doi: 10.1016/0002-9343(87)90702-9.

Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.

J Med Chem. 1985 Jul;28(7):841-9. doi: 10.1021/jm00145a001.

[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].

Nihon Rinsho. 1987 Dec;45(12):3010-27.

Aldose reductase inhibitors and diabetic complications.

Pharmacol Ther. 1992;54(2):151-94. doi: 10.1016/0163-7258(92)90031-t.

[Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].

Rev Med Interne. 1992 Jan-Feb;13(1):69-79. doi: 10.1016/s0248-8663(05)80015-3.

The pharmacology of aldose reductase inhibitors.

Annu Rev Pharmacol Toxicol. 1985;25:691-714. doi: 10.1146/annurev.pa.25.040185.003355.

The pharmacology of diabetic complications.

Curr Med Chem. 2003 Aug;10(15):1317-27. doi: 10.2174/0929867033457287.

[Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].

Rev Assoc Med Bras (1992). 1996 Apr-Jun;42(2):109-14.

The role of aldose reductase inhibitors in diabetic complications: recent trends.

Methods Find Exp Clin Pharmacol. 2001 Oct;23(8):465-75. doi: 10.1358/mf.2001.23.8.662134.

引用本文的文献

Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

J Clin Invest. 1999 Apr;103(7):1007-13. doi: 10.1172/JCI4711.

Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Drugs. 1997 Aug;54(2):197-234. doi: 10.2165/00003495-199754020-00002.

Metabolic cataracts in newly diagnosed diabetes.

Arch Dis Child. 1997 Feb;76(2):118-20. doi: 10.1136/adc.76.2.118.

The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Drugs Aging. 1995 Jan;6(1):9-28. doi: 10.2165/00002512-199506010-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Aldose reductase inhibitors and the complications of diabetes mellitus.

作者信息

Tomlinson D R

机构信息

Department of Pharmacology, Queen Mary and Westfield College, London, UK.

出版信息

Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.

DOI:10.1111/j.1464-5491.1993.tb00049.x

PMID:8485953

Abstract

摘要

相似文献

Aldose reductase inhibitors and the complications of diabetes mellitus.

Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x.

Aldose reductase inhibitors and diabetic complications.

Am J Med. 1987 Aug;83(2):298-306. doi: 10.1016/0002-9343(87)90702-9.

Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.

J Med Chem. 1985 Jul;28(7):841-9. doi: 10.1021/jm00145a001.

[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].

Nihon Rinsho. 1987 Dec;45(12):3010-27.

Aldose reductase inhibitors and diabetic complications.

Pharmacol Ther. 1992;54(2):151-94. doi: 10.1016/0163-7258(92)90031-t.

[Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].

Rev Med Interne. 1992 Jan-Feb;13(1):69-79. doi: 10.1016/s0248-8663(05)80015-3.

The pharmacology of aldose reductase inhibitors.

Annu Rev Pharmacol Toxicol. 1985;25:691-714. doi: 10.1146/annurev.pa.25.040185.003355.

The pharmacology of diabetic complications.

Curr Med Chem. 2003 Aug;10(15):1317-27. doi: 10.2174/0929867033457287.

[Treatment of chronic complications of diabetes mellitus with aldose reductase inhibitors].

Rev Assoc Med Bras (1992). 1996 Apr-Jun;42(2):109-14.

The role of aldose reductase inhibitors in diabetic complications: recent trends.

Methods Find Exp Clin Pharmacol. 2001 Oct;23(8):465-75. doi: 10.1358/mf.2001.23.8.662134.

引用本文的文献

Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

J Clin Invest. 1999 Apr;103(7):1007-13. doi: 10.1172/JCI4711.

Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Drugs. 1997 Aug;54(2):197-234. doi: 10.2165/00003495-199754020-00002.

Metabolic cataracts in newly diagnosed diabetes.

Arch Dis Child. 1997 Feb;76(2):118-20. doi: 10.1136/adc.76.2.118.

The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Drugs Aging. 1995 Jan;6(1):9-28. doi: 10.2165/00002512-199506010-00002.